Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZAI LAB

17.220
-0.040-0.23%
Volume:1.34M
Turnover:22.85M
Market Cap:19.25B
PE:-8.53
High:17.240
Open:16.910
Low:16.910
Close:17.260
52wk High:35.500
52wk Low:16.810
Shares:1.12B
HK Float Shares:1.12B
Volume Ratio:0.55
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.019
ROE:-28.97%
ROA:-13.29%
PB:3.26
PE(LYR):-8.53
PS:5.61

Loading ...

JPMorgan Increases Stake in Zai Lab (09688) by Approximately 611,105 Shares at HK$20.56 per Share

Stock News
·
Oct 31

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31

UBS Initiates “Buy” Rating on Zai Lab (09688) with Clear Catalysts Ahead but Undervalued

Stock News
·
Oct 27

Zai Lab Unveils Promising Phase 1 Data for DLL3 ADC; Launches Global Phase 3 Trial

Reuters
·
Oct 24

Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (Formerly Zl-1310), Demonstrating Potential as a First-in-Class/Best-in-Class Dll3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study

THOMSON REUTERS
·
Oct 24

Zai Lab Ltd: First-Line Sclc & Neuroendocrine Carcinoma Programs Advancing Toward Registrational Phase in 2026

THOMSON REUTERS
·
Oct 24

Zai Lab Ltd - Global Phase 3 Trial Initiated for Second-Line Sclc

THOMSON REUTERS
·
Oct 24

Zai Lab Launches Global Phase 3 Trial of DLL3-Targeted ADC for Small Cell Lung Cancer

Reuters
·
Oct 24

Zai Lab Limited (Stock Code: 9688) Announces Audit Committee Action and Q3 2025 Results Release Schedule

Bulletin Express
·
Oct 23

Zai Lab Limited Announces Updated Nominating and Corporate Governance Committee Charter

Bulletin Express
·
Oct 23

Stock Track | Zai Lab Plummets 5.23% Following RMB300 Million Loan Guarantee Agreement

Stock Track
·
Oct 17

Stock Track | Zai Lab Plummets 5.23% Following Announcement of RMB300 Million Guarantee Contract

Stock Track
·
Oct 17

Zai Lab Secures 300 Million Yuan Credit Line

MT Newswires Live
·
Oct 17

Zai Lab Ltd - on Oct 13, Enters Maximum Amount Guarantee Contract - SEC Filing

THOMSON REUTERS
·
Oct 17

Zai Lab Secures RMB300 Million Revolving Credit Facility from Industrial Bank Co., Ltd. to Support China Operations

Reuters
·
Oct 17

Short Selling Statistics for Hong Kong Stocks | October 16

Stock News
·
Oct 16

Zai Lab Ltd. to Announce Third Quarter 2025 Financial Results

Reuters
·
Oct 15

Zai Lab Announces Updated Phase 1 Data for DLL3-Targeted ADC Zocilurtatug Pelitecan in Small Cell Lung Cancer at 2025 AACR-NCI-EORTC Conference

Reuters
·
Oct 14

Zai Lab Announces Oral Presentation of Updated Data From Global Phase 1 Trial of Zocilurtatug Pelitecan (Zl-1310), a Potential First-in-Class Dll3-Targeted ADC, at 2025 Aacr-Nci-Eortc Conference

THOMSON REUTERS
·
Oct 14

Stock Track | ZAI LAB Plummets 5.04% Amid Broader Biomedical Sector Decline in Hong Kong

Stock Track
·
Oct 13